At Nexogen ImmunoTech, we’re rewriting the rules of disease prevention. Our breakthrough platform is designed to develop universal vaccines—next-generation immunizations that provide broad, long-lasting protection against rapidly evolving pathogens.
Traditional vaccines target specific strains, requiring constant updates. Our science-driven approach focuses on conserved pathogen structures, enabling a single vaccine to defend against multiple variants—even future mutations. The result? Stronger, longer immunity with fewer doses.
To eliminate the threat of infectious diseases through innovative, adaptable vaccines that protect human health and global food security. By advancing universal vaccine technology, we aim to:
✔ Eradicate seasonal vaccine updates for flu, coronaviruses, and more.
✔ Safeguard livestock from devastating outbreaks, ensuring stable food supplies.
✔ Outpace pandemics with rapid-response, broad-spectrum solutions.
🔬 Cutting-Edge Science: Leveraging AI-driven antigen design and novel adjuvant systems.
🌍 Global Impact: Solutions for both human medicine and veterinary health.
⚡ Scalable Solutions: Engineered for fast deployment in high-need settings.
Nexogen ImmunoTech is emerging from stealth—backed by leading scientists and investors—to redefine vaccine development. Stay ahead of pathogens. Stay protected.